Skip to main content
Clinical Trials/IRCT20211130053229N1
IRCT20211130053229N1
Recruiting
Phase 1

Comparison of the effect of intravitreal injection of Bevacizumab (Stevenet) alone with intravitreal injection of Bevacizumab and Triamcinolone in the treatment of diabetic macular edema with a thickness greater than 500 microns in patients referred to Shafa Hospital.

Kerman University of Medical Sciences0 sites70 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Kerman University of Medical Sciences
Enrollment
70
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with clinically significant DME according to ETDRS criteria
  • Patients with clinically significant DME based on criteria of central thickness greater than 500 microns

Exclusion Criteria

  • History of previous DME treatment (focal or panretinal laser coagulation or IVB or IVT)
  • Eye surgery
  • Glaucoma or ocular hypertension
  • monocular vision
  • Significant media opacity
  • The patient's absence in follow\-up in the following weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials